U.S. stock indexes drift higher in afternoon trading
Major stock indexes edged higher in afternoon trading Monday, on course to build on gains from last week. Pharmaceutical stocks were among the big risers. Discouraging data on U.S. home sales and a deepening slide in oil prices held back the rally.
The Dow Jones industrial average rose 131 points, or 0.7 percent, to 17,936 as of 3:25 p.m. ET. The Standard & Poor's 500 index gained seven points, or 0.3 percent, to 2,077. The Nasdaq composite added 14 points, or 0.3 percent, to 4,780.
Stocks are extending a pre-Christmas advance, which traders often refer to as a "Santa" rally. Major indexes ended last week on a strong note, finishing higher three days in a row. The Dow and S&P 500 are both up for the month, while the Nasdaq is down.
"With the Dow being up substantially more than the S&P 500, I would tend to say what's holding back the S&P is more related to its makeup than it is a problem related to investors' perception or concerns," said Sam Stovall, U.S. equity strategist at S&P Capital IQ. "We're firmly in a Santa Claus rally."
Seven of the 10 sectors in the S&P 500 index rose, led by technology stocks. Energy stocks declined. The sector is down 9.3 percent this year.
Achillion Pharmaceuticals' shares gained 10.5 percent after the biotechnology company reported positive results from two studies focusing on a treatment regimen for hepatitis C patients. The stock rose $1.49 to $15.70. Meanwhile, Enanta Pharmaceuticals vaulted 8.6 percent after it received regulatory approval for a hepatitis C treatment. Enanta added $4 to $50.62.
Electronic weapons and body camera maker Taser International says it received nearly 1,900 product orders and expects to ship during the fourth quarter. The stock surged $1.85, or 7.7 percent, to $25.83.
Shares in Caesar's Entertainment jumped 12.6 percent on news the casino operator will buy an affiliate in a bid to smooth the reorganization of another struggling division and balance its debt load. The stock gained $1.70 to $15.19.
The National Association of Realtors reported that sales of previously occupied homes fell 6.1 percent last month to a seasonally adjusted annual rate of 4.93 million. That's the slowest pace in six months. Over the past 12 months, sales have risen 2.1 percent. The disappointing data initially sent shares in most homebuilders lower. The sector bounced back by afternoon, led by William Lyon Homes. The stock added 54 cents, or 2.9 percent, to $19.40.
Shares in drugmaker Gilead Sciences fell 13.6 percent after pharmacy benefits manager Express Scripts said it will no longer cover two of Gilead's hepatitis C drugs as part of an effort to battle the high cost of treatment for the disease. Gilead slid $14.75 to $93.73.
Ocwen Financial slid 26.2 percent on news that the subprime mortgage servicer's executive chairman will resign in a settlement that also provides $150 million to homeowners. The stock shed $5.73 to $16.17.
Benchmark U.S. crude fell $1.77, or 3.1 percent, to $55.36 a barrel. Oil peaked at $107 a barrel in June but has plunged since then due to weak demand and abundant supplies, especially after Saudi Arabia and other OPEC members agreed to maintain production levels.
Several oil production and exploration companies tumbled as the slide in oil prices deepened. Nabors Industries fell 53 cents, or 3.9 percent, to $13.10, while Chesapeake Energy slid $1.33, or 6.7 percent, to $18.53. Range Resources shed $2.58, or 4.3 percent, to $57.29. Southwestern Energy dropped $1.80, or 5.8 percent, to $29.20.
Britain's FTSE 100 rose 0.5 percent, while Germany's DAX rose 0.8 percent. France's CAC 40 gained 0.3 percent.
The yield on the 10-year Treasury note was flat at 2.17 percent.
More details on: cbsnews.com